Dr. Quirk is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Bristol Myers Squibb
3401 Princeton Pike
Lawrence Township, NJ 08648
Education & Training
- Massachusetts General HospitalFellowship, Gastroenterology, 1994 - 1997
- Johns Hopkins UniversityResidency, Internal Medicine, 1991 - 1994
- The Warren Alpert Medical School of Brown UniversityClass of 1991
Certifications & Licensure
- PA State Medical License 2008 - 2024
Awards, Honors, & Recognition
- Top MD Consumers Checkbook
Publications & Presentations
PubMed
- 6 citationsRetrospective Database Analysis: Dose Escalation and Adherence in Patients Initiating Biologics for Ulcerative Colitis.Millie D Long, Russell D Cohen, Timothy W Smith, Marco DiBonaventura, David Gruben
Digestive Diseases. 2022-01-01 - 293 citationsTofacitinib in Patients Hospitalized with Covid-19 Pneumonia.Patrícia O. Guimarães, Daniel Quirk, Remo H. Furtado, Lilia N. Maia, José F. Saraiva
The New England Journal of Medicine. 2021-07-29 - 17 citationsLipid Profiles in Patients With Ulcerative Colitis Receiving Tofacitinib-Implications for Cardiovascular Risk and Patient Management.Bruce E. Sands, Jean-Frederic Colombel, Christina Ha, Michel Farnier, Alessandro Armuzzi
Inflammatory Bowel Diseases. 2021-05-17
Press Mentions
- Bristol Myers Squibb Presents New Data from Two Trials Demonstrating Sotyktu (Deucravacitinib) Efficacy in Both Moderate-to-Severe Scalp Psoriasis and in a Real-World SettingSeptember 27th, 2024
- Philadelphia's Thomas Jefferson University Hospital Opens Barrett's Esophagus Treatment CenterFebruary 13th, 2016
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: